VR treatment for lazy eye in children gets FDA approval
Posted On October 20, 2021
The Food and Drug Administration approved a virtual reality-based treatment for children with the visual disorder amblyopia, or lazy eye, the company behind the therapy announced today. Patients watch modified TV shows or movies through a virtual reality headset to improve their vision.
“We’re proud to be part of the FDA’s groundbreaking decision today, to approve a first-of-its-kind digital therapeutic that allows patients to watch their favorite TV shows and movies to improve their vision,” Scott Xiao, chief executive officer of Luminopia, the company that developed the tool, said in a statement.
Around 3 percent of children have amblyopia, which develops when the brain and eyes stop communicating properly. The brain favors one eye,…